Drug Delivery Partnerships DDP 2006 - January 25-27, 2006

Drug Delivery Partnerships DDP 2006 - January 25-27, 2006
Rave Reviews for DDP 2005:
?Broader and more informative than expected. This conference needs to continue to bring the product developers and drug delivery companies together. I think that anyone who is involved in drug development should attend. - CEO, Solstice Neurosciences
?[The main reason I attended the DDP event was] economy of motion. In one trip, I can access and consult with most of the leading providers of drug delivery platform technologies. The speakers and technical content are top-notch.? - Vice President R&D, KING PHARMACEUTICALS
?Good blend of technology awareness, commercial drivers of technology, partnering and expert opinions? - Associate Research Fellow, Pharmaceutical R&D, PFIZER
Who Should Attend:
Join over 600 senior-level drug delivery and development professionals and take a critical step in developing and delivering the deal. Plan to attend if you are a Senior Professional at a Pharmaceutical, Biotech, Consumer Product/OTC and Generic Drug Company and work within any of the following departments:
Business Development
Licensing
Technology Transfer
Technology Assessment
Commercial Development
Patents
Life Cycle Management
Strategic Planning and Development
Financial Analyst
Pharmaceutical and Analytical R&D
Preformulation
Formulation
Stability testing
Drug Delivery Scientists
Protein Development
Sustained/Controlled Release
Clinical Pharmacology
Product Development
New Product Planning
New Technology Evaluation
Marketing and Sales
Regulatory Affairs
Senior Executives at Drug Delivery and Specialty Pharmaceutical Companies who work in the following departments:
Business Development
Marketing
Formulation Sciences
Technology Development
Commercial Development
Corporate Development
Research & Development
The event is also of interest to:
Medical Device Companies who have an arm of their business dedicated to developing and manufacturing delivery devices
Intellectual Property attorneys from pharma, biotech and drug delivery companies
Venture Capitalists, interested in knowing about new partnerships between emerging
technology or biotech companies or academia and pharma or drug delivery companies
Analysts at investment banks and market research companies, tracking industry progress and making projections based on company and industry performance
CROs, developing new drugs formed by partnered companies
Universities and government research labs requiring a partner for commercial development of new technology
Excipient makers
Specialty chemicals/Raw material producers
Drug delivery device designers/manufacturers
Testing and manufacturing equipment companies
Packaging companies